Analyst Consensus ?
ConsensusBuy31 ratings
Bullish2167.8%
Neutral929.0%
Bearish13.2%
CoreWeave, Inc. Class A Common Stock · CRWV · FY2025 Q4 · Calendar Q1 2026
CoreWeave raises outlook as AI demand drives capacity expansion
The current analysis supports the view that strong AI demand and contracted backlog can underpin continued growth, but the one-year case depends on converting capacity and backlog into revenue without allowing capex, margin, financing, or supply-chain pressures to overwhelm operating leverage.
Reported After market closeNASDAQTechnology
$48.32B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$-0.56
Consensus $-0.50
EPS surprise
-11.7%
Reported versus consensus
Reported revenue
$1.57B
Consensus $1.55B
Revenue surprise
+1.5%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-18.5%
Event window
SPY move
-0.5%
Same window
Abnormal move
-18.0%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
-6.0%
Up to 20 sessions
CRWVSPY benchmark
Ask FN2 about CRWV FY2025 Q4
Transcript, numbers and history already loaded
Why did CRWV fall 18.5% after missing EPS estimates in FY2025 Q4?What changed in CRWV's guidance and outlook in FY2025 Q4?Give me the bull and bear case for CRWV after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, management’s posture is more expansionary: guidance sentiment is raised, the capacity roadmap is larger, and the company is emphasizing proprietary-stack licensing and new infrastructure products. The analysis also makes the near-term cost of that expansion more explicit through expected margin pressure.
Guidance delta
Guidance sentiment moved from maintained in the prior analysis to raised in the current analysis, alongside a materially more aggressive capacity and capex plan.
Key takeaways
- Management described relentless AI workload demand and reported strong growth with a $66.8 billion contracted revenue backlog.
- The company plans more than $30 billion of 2026 capex and over 5 GW of additional data-center capacity by 2030.
- The expanded NVIDIA relationship includes licensing of CoreWeave’s proprietary cloud stack and a reported strategic investment.
- The central tension is high visibility into demand versus near-term margin pressure and financing risk from rapid expansion.
Management priorities
- Scale data-center capacity across North America and Europe.
- Bring Rubin GPU, Vera CPU, and BlueField storage offerings to market.
- Cross-sell storage, CPU, and software services across the platform.
- Monetize the proprietary cloud stack through licensing and continue strategic acquisitions.
Follow CRWV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$89.62Current
$58Low
$131.39Average
$250High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Rosenblatt | Buy | Buy | Maintain | Oct 1, 2026 |
| Freedom Capital Markets | Buy | Buy | Maintain | Sep 30, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 24, 2026 |
| Truist Securities | Buy | Buy | Maintain | Aug 24, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Aug 21, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 14, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 12, 2026 |
| Macquarie | Outperform | Outperform | Maintain | Aug 12, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Bernstein | Underperform | Underperform | Maintain | Aug 12, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 12, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 21, 2026 |
| DA Davidson | Neutral | Buy | Downgrade | May 18, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 29, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Mar 9, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Mar 2, 2026 |
| Needham | Hold | Hold | Maintain | Feb 27, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Feb 27, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Jan 27, 2026 |
| Loop Capital | Buy | Buy | Maintain | Nov 12, 2025 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Nov 11, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Nov 11, 2025 |
| Melius Research | Buy | Hold | Upgrade | Sep 23, 2025 |
| JMP Securities | Market Outperform | Market Perform | Upgrade | Sep 16, 2025 |
| MoffettNathanson | Neutral | Neutral | Maintain | Aug 19, 2025 |
| Argus Research | Buy | Buy | Maintain | Aug 14, 2025 |
| Stifel | Hold | Hold | Maintain | Aug 13, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Jul 18, 2025 |
Named analyst price targets
Upside is calculated against the persisted current price $89.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Rosenblatt Securities | John McPeake | $250 | $87.12 | +179.0% | Oct 1, 2026 |
| UBS | Analyst unavailable | $120 | $86.76 | +33.9% | Sep 22, 2026 |
| BTG Pactual | Analyst unavailable | $125 | $85.66 | +39.5% | Sep 21, 2026 |
| Truist Financial | Arvind Ramnani | $165 | $83.84 | +84.1% | Aug 24, 2026 |
| Goldman Sachs | Gabriela Borges | $139 | $89.76 | +55.1% | Aug 21, 2026 |
| Roth Capital | Analyst unavailable | $145 | $111.16 | +61.8% | Aug 13, 2026 |
| Barclays | Analyst unavailable | $105 | $107.73 | +17.2% | Aug 13, 2026 |
| Truist Financial | Arvind Ramnani | $155 | $106.77 | +73.0% | Aug 12, 2026 |
| Piper Sandler | James Fish | $153 | $106.75 | +70.7% | Aug 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $176 | $109.92 | +96.4% | Aug 12, 2026 |
| Bernstein | Analyst unavailable | $74 | $107.96 | -17.4% | Aug 12, 2026 |
| Cantor Fitzgerald | Brett Knoblauch | $178 | $90.32 | +98.6% | Aug 12, 2026 |
| Wells Fargo | Michael Turrin | $160 | $90.32 | +78.5% | Aug 12, 2026 |
| Mizuho Securities | Gregg Moskowitz | $115 | $90.32 | +28.3% | Aug 12, 2026 |
| Robert W. Baird | Rob Oliver | $130 | $90.32 | +45.1% | Aug 12, 2026 |
| Deutsche Bank | Analyst unavailable | $150 | $85.33 | +67.4% | Aug 7, 2026 |
| Piper Sandler | James Fish | $151 | $85.76 | +68.5% | Aug 3, 2026 |
| Truist Financial | Analyst unavailable | $126 | $79.58 | +40.6% | Jul 21, 2026 |
| Robert W. Baird | Rob Oliver | $100 | $79.58 | +11.6% | Jul 21, 2026 |
| Jefferies | Brent Thill | $150 | $73.06 | +67.4% | Jul 21, 2026 |
| BNP Paribas | Analyst unavailable | $192 | $124.82 | +114.2% | Jun 2, 2026 |
| D.A. Davidson | Gil Luria | $100 | $101.3 | +11.6% | May 18, 2026 |
| Barclays | Analyst unavailable | $120 | $114.15 | +33.9% | May 11, 2026 |
| Deutsche Bank | Analyst unavailable | $135 | $116.18 | +50.6% | May 8, 2026 |
| Truist Financial | Analyst unavailable | $131 | $128.84 | +46.2% | May 8, 2026 |
| Wells Fargo | Michael Turrin | $155 | $128.84 | +73.0% | May 8, 2026 |
| Roth Capital | Analyst unavailable | $150 | $128.84 | +67.4% | May 8, 2026 |
| Mizuho Securities | Analyst unavailable | $110 | $128.84 | +22.7% | May 8, 2026 |
| Jefferies | Analyst unavailable | $160 | $125.43 | +78.5% | May 4, 2026 |
| Oppenheimer | Analyst unavailable | $150 | $105.53 | +67.4% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $106 | $113.52 | +18.3% | Apr 20, 2026 |
| Cantor Fitzgerald | Brett Knoblauch | $156 | $118.69 | +74.1% | Apr 16, 2026 |
| Wolfe Research | Analyst unavailable | $150 | $118.69 | +67.4% | Apr 16, 2026 |
| Evercore ISI | Analyst unavailable | $150 | $118.42 | +67.4% | Apr 15, 2026 |
| Bernstein | Madison Rezaei | $67 | $110.27 | -25.2% | Apr 14, 2026 |
| Mizuho Securities | Analyst unavailable | $105 | $110.27 | +17.2% | Apr 14, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $149 | $92 | +66.3% | Apr 9, 2026 |
| Evercore ISI | Analyst unavailable | $120 | $74.41 | +33.9% | Mar 9, 2026 |
| MoffettNathanson | Nick Del Deo | $92 | $74.41 | +2.7% | Mar 9, 2026 |
| Deutsche Bank | Analyst unavailable | $140 | $98.31 | +56.2% | Jan 27, 2026 |
| Mizuho Securities | Gregg Moskowitz | $100 | $98.57 | +11.6% | Jan 26, 2026 |
| D.A. Davidson | Analyst unavailable | $110 | $100.94 | +22.7% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $90 | $80.14 | +0.4% | Jan 12, 2026 |
| Goldman Sachs | Analyst unavailable | $86 | $80.14 | -4.0% | Jan 12, 2026 |
| Wells Fargo | Analyst unavailable | $125 | $77.18 | +39.5% | Jan 8, 2026 |
| Truist Financial | Analyst unavailable | $84 | $76.86 | -6.3% | Jan 6, 2026 |
| Jefferies | Brent Thill | $120 | $80.2 | +33.9% | Jan 5, 2026 |
| D.A. Davidson | Analyst unavailable | $68 | $79.32 | -24.1% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $92 | $72.34 | +2.7% | Dec 16, 2025 |
| Roth Capital | Analyst unavailable | $110 | $85.75 | +22.7% | Dec 4, 2025 |
| Melius Research | Analyst unavailable | $140 | $105.61 | +56.2% | Nov 11, 2025 |
| Jefferies | Analyst unavailable | $155 | $105.61 | +73.0% | Nov 11, 2025 |
| Stifel Nicolaus | Ruben Roy | $120 | $105.61 | +33.9% | Nov 11, 2025 |
| Mizuho Securities | Gregg Moskowitz | $120 | $105.61 | +33.9% | Nov 11, 2025 |
| Evercore ISI | Analyst unavailable | $175 | $122.52 | +95.3% | Sep 30, 2025 |
| Melius Research | Ben Reitzes | $165 | $133.23 | +84.1% | Sep 23, 2025 |
| Wells Fargo | Michael Turrin | $170 | $133.23 | +89.7% | Sep 23, 2025 |
| Loop Capital Markets | Analyst unavailable | $165 | $121.39 | +84.1% | Sep 18, 2025 |
| Raymond James | Josh Beck | $130 | $120.47 | +45.1% | Sep 15, 2025 |
| Cantor Fitzgerald | Thomas Blakey | $116 | $91.39 | +29.4% | Aug 26, 2025 |
| Stifel Nicolaus | Ruben Roy | $115 | $159.7 | +28.3% | Jul 8, 2025 |
| Goldman Sachs | Kash Rangan | $61 | $65.77 | -31.9% | May 15, 2025 |
| Northland Securities | Nehal Chokshi | $85 | $65.77 | -5.2% | May 15, 2025 |
| D.A. Davidson | Gil Luria | $36 | $65.77 | -59.8% | May 15, 2025 |
| Stifel Nicolaus | Ruben Roy | $75 | $65.77 | -16.3% | May 15, 2025 |
| Morgan Stanley | Keith Weiss | $58 | $65.77 | -35.3% | May 15, 2025 |
| Deutsche Bank | Analyst unavailable | $45 | $38.51 | -49.8% | Apr 22, 2025 |
| Wells Fargo | Analyst unavailable | $41 | $38.51 | -54.3% | Apr 22, 2025 |
| Barclays | Analyst unavailable | $48 | $38.51 | -46.4% | Apr 22, 2025 |
Track every rating change on CRWV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationCoreWeave, Inc. operates a specialized cloud computing platform designed to empower generative AI (GenAI) applications. It constructs the fundamental infrastructure necessary to manage intensive compute workloads for large enterprises. The company's comprehensive suite of offerings includes high-performance GPU and CPU compute resources, robust storage solutions, advanced networking capabilities, and fully managed services. Clients can choose from flexible virtual servers or powerful bare-metal options. Beyond core hardware, its platform integrates sophisticated tools like a fleet lifecycle controller, a node lifecycle controller, Tensorizer, and advanced observability features. CoreWeave's expertise also extends to specialized services, such as visual effects (VFX) and rendering, AI model training, AI inference, and "Mission Control." Originally incorporated in 2017 as Atlantic Crypto Corporation, the company rebranded to CoreWeave, Inc. in December 2019 and is headquartered in Livingston, New Jersey.
Historical context
All CRWV earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ACN Accenture plc | FY2026 Q4 · Calendar Q4 2026 | +3.5% | +15.8% | Accenture: AI demand supports strong Q4, while pricing and geopolitics remain risks |
| JBL Jabil Inc. | FY2026 Q4 · Calendar Q3 2026 | +8.1% | -10.0% | Jabil enters FY2027 with AI-led growth and capacity risks |
| MU Micron Technology, Inc. | FY2026 Q4 · Calendar Q3 2026 | +5.4% | +0.0% | Micron: Strong AI Memory Demand, Higher Capex, and HBM4E Ahead |
| SNX TD Synnex Corp | FY2026 Q3 · Calendar Q3 2026 | +20.9% | -9.9% | TD SYNNEX: AI-led growth accelerates, but mix and cash flow matter |
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the CRWV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-02T20:16:03.012318+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-02T20:16:03.009288+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-02. For educational purposes only; not investment advice.